Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-20

Clinical Trial Update: Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?

View source ↗

Summary

An update on a clinical trial evaluating the value of axillary ultrasound for staging breast cancer and whether the use of BSGC is still necessary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Corporacion Parc Tauli | Conditions: Breast Cancer | Status: UNKNOWN